The FERM domain: organizing the structure and function of FAK

MC Frame, H Patel, B Serrels, D Lietha… - Nature reviews Molecular …, 2010 - nature.com
Focal adhesion kinase (FAK) is a scaffold and tyrosine kinase protein that binds to itself and
cellular partners through its four-point-one, ezrin, radixin, moesin (FERM) domain. Recent …

[PDF][PDF] Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity

A Serrels, T Lund, B Serrels, A Byron, RC McPherson… - Cell, 2015 - cell.com
Focal adhesion kinase (FAK) promotes anti-tumor immune evasion. Specifically, the kinase
activity of nuclear-targeted FAK in squamous cell carcinoma (SCC) cells drives exhaustion of …

Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex

B Serrels, A Serrels, VG Brunton, M Holt… - Nature cell …, 2007 - nature.com
Networks of actin filaments, controlled by the Arp2/3 complex, drive membrane protrusion
during cell migration. How integrins signal to the Arp2/3 complex is not well understood. Here, …

Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor …

VG Brunton, E Avizienyte, VJ Fincham, B Serrels… - Cancer research, 2005 - AACR
Src tyrosine kinase expression and activity are elevated during colon cancer progression.
How this contributes to the malignant phenotype is not fully understood. We show that in …

Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression

GW McLean, NH Komiyama, B Serrels… - Genes & …, 2004 - genesdev.cshlp.org
We have generated mice with a floxed fak allele under the control of keratin-14-driven Cre
fused to a modified estrogen receptor (CreER T2 ). 4-Hydroxy-tamoxifen treatment induced …

[HTML][HTML] Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein …

…, M Pawlak, EF Petricoin, HB Pollard, B Serrels… - Molecular & cellular …, 2014 - ASBMB
Reverse phase protein array (RPPA) technology introduced a miniaturized "antigen-down"
or "dot-blot" immunoassay suitable for quantifying the relative, semi-quantitative or …

Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling

E Sandilands, B Serrels, DG McEwan, JP Morton… - Nature cell …, 2012 - nature.com
Here we describe a mechanism that cancer cells use to survive when flux through the Src/FAK
pathway is severely perturbed. Depletion of FAK, detachment of FAK-proficient cells or …

Quantitative In vivo Imaging of the Effects of Inhibiting Integrin Signaling via Src and FAK on Cancer Cell Movement: Effects on E-cadherin Dynamics

M Canel, A Serrels, D Miller, P Timpson, B Serrels… - Cancer research, 2010 - AACR
Most cancer-related deaths are due to the development of metastatic disease, and several
new molecularly targeted agents in clinical development have the potential to prevent …

[PDF][PDF] A complex between FAK, RACK1, and PDE4D5 controls spreading initiation and cancer cell polarity

B Serrels, E Sandilands, A Serrels, G Baillie… - Current Biology, 2010 - cell.com
A fundamental question in cell biology concerns how cells respond to their environment by
polarizing after sensing directional cues. This requires the differential localization of protein …

[HTML][HTML] Harnessing CD3 diversity to optimize CAR T cells

…, A Buschky, T Peters, F Beier, B Serrels… - Nature …, 2023 - nature.com
Current US Food and Drug Administration-approved chimeric antigen receptor (CAR) T
cells harbor the T cell receptor (TCR)-derived ζ chain as an intracellular activation domain in …